Fidelity Management & Research Overview
- Investor Type
- Asset Manager
- Status
- Active
- Professionals
- 5
- Investments
- 153
- Portfolio
- 78
- Exits
- 72
Fidelity Management & Research General Information
Description
Fidelity Management & Research is an investment manager that caters to pooled investment vehicles and other investment advisors. The firm specializes in equity, fixed income and balanced mutual funds for its clients. It was founded in 1946 and is headquartered in Boston, Massachusetts.
Contact Information
Year Founded
1946
Investor Status
Actively Seeking New Investments
Primary Investor Type
Asset Manager
Other Investor Types
Lender/Debt Provider
Mutual Fund
Venture Capital
Primary Office
- 245 Summer Street
- Boston, MA 02210
- United States
+1 (617) 000-0000
Fidelity Management & Research Investments (153)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Conformal Medical | 06-Aug-2020 | Later Stage VC | 0000 | Therapeutic Devices | Clinical Trials - General | |
| 0000 00000 | 06-Aug-2020 | 00000 00000 | 00.000 | Entertainment Software | Generating Revenue | |
| 000000 0000 000000 | 05-Aug-2020 | 00000 00000 | 0000 | Drug Discovery | Startup | |
| 0000000 0000000000 | 30-Jul-2020 | 0000 | 00000 | Drug Discovery | Generating Revenue | |
| 00 00000000 (00 00 | 27-Jul-2020 | 0000000000 | Buildings and Property | Generating Revenue | ||
| 000000000 | 20-Jul-2020 | 00000 00000 | 0000 | Pharmaceuticals | Generating Revenue | |
| 000000 00000000000 | 16-Jul-2020 | 00000 00000 | 0000 | Drug Discovery | Product Development | |
| 000000 0000000000 | 11-Jul-2020 | 00 000000000 | 00.00 | Automotive | Generating Revenue | |
| Poseida Therapeutics | 24-Jun-2020 | Later Stage VC | 00000 | Drug Discovery | Clinical Trials - Phase 2 | |
| Yumanity Therapeutics | 24-Jun-2020 | Later Stage VC | 000.00 | Drug Discovery | Generating Revenue |
Fidelity Management & Research Exits (70)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| AlloVir | 31-Jul-2020 | IPO | 00000 |
| 0000000 0000000000 | 02-Jul-2020 | 000000000000000000 | 00.000 |
| 000000 | 26-Jun-2020 | 000 | 00000 |
| 0000000000 000 | 12-Jun-2020 | 000 | 00000 |
| 000000000 00000000 | 05-Jun-2020 | 000000 0000000000 | 00.000 |
| 0000 0000000000000 | 24-Apr-2020 | 000 | 00000 |
| 0000000000 0000000 | 13-Feb-2020 | 000 | 00000 |
| 00000 000000000000 | 01-Nov-2019 | 000 00 00000000 | |
| BioNTech | 10-Oct-2019 | IPO | 00000 |
| Oportun | 26-Sep-2019 | IPO | 000.00 |
Fidelity Management & Research Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialFidelity Management & Research Team (6)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Jean Raymond | Chief Financial Officer of Asset Management | Boston, MA | |||
| William Dailey | Chief Operating Officer of Asset Management & Treasurer | Boston, MA | |||
| Scott Goebel JD | Senior Vice President, Secretary & General Counsel | Boston, MA | |||
| William Bower | Portfolio Manager, Fidelity Diversified International Fund & Equity Division, Fidelity Investments | Boston, MA | |||
| J. S. Wynant | Senior Vice President | Boston, MA |
Fidelity Management & Research Co-Investors (374)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| T. Rowe Price | 12 | 0 |
|
|
|
| ARCH Venture Partners | 0 | 0 | 0 |
|
|
| Casdin Capital | 0 | 0 |
|
|
|
| The Invus Group | 0 |
|
|
||
| EcoR1 Capital | 0 |
|
|